[1]
M. Sisay, J. Abdela, and Y. Molla, “THE MOLECULAR TRIAD SYSTEM INVOLVING RANK/RANKL/OPG AS THERAPEUTIC TARGETS FOR METABOLIC BONE DISEASES”, J. Drug Delivery Ther., vol. 6, no. 6, pp. 31–39, Nov. 2016, doi: 10.22270/jddt.v6i6.1341.